Kelly Leanne 4
4 · GRI Bio, Inc. · Filed Jan 24, 2025
Insider Transaction Report
Form 4
Kelly Leanne
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-01-23$0.69/sh+43,319$29,704→ 43,319 totalExercise: $0.69From: 2025-01-23Exp: 2035-01-23→ Common Stock (43,319 underlying)